Structure and function of a recombinant von Willebrand factor drug candidate

Seminars in Thrombosis and Hemostasis
Peter L TurecekHans Peter Schwarz

Abstract

The complex structure, large size, and multiple posttranslational modifications of von Willebrand factor (VWF) presented a technological challenge for the production of recombinant VWF (rVWF). Nonetheless, we developed an rVWF product for treating von Willebrand disease, whereupon rVWF is coexpressed with recombinant factor VIII (rFVIII) in Chinese hamster ovary cells used to produce rFVIII for the treatment of hemophilia A. Here we describe the characterization of the structure and function of the rVWF drug product, with a focus on its in vitro platelet aggregation and matrix protein binding functions. Electron microscopy and multimer analysis revealed a highly organized structure for the rVWF protein, with a homogeneous multimer distribution including ultrahigh molecular weight multimers. The specific activity for binding to collagen and platelets mediated by ristocetin is higher in rVWF than in commercial plasma-derived VWF-FVIII complex products. The affinity and binding capacity of rVWF to FVIII is comparable to VWF in plasma. rVWF effectively binds to platelets and promotes platelet adhesion under shear stress similar to VWF in human plasma.

Citations

Mar 21, 2012·Expert Opinion on Biological Therapy·Emmanuel J FavaloroGiuseppe Lippi
Feb 5, 2016·Haemophilia : the Official Journal of the World Federation of Hemophilia·M V RagniD J Brambilla
Mar 6, 2012·American Journal of Hematology·Paula D James, David Lillicrap
May 31, 2012·Journal of Thrombosis and Haemostasis : JTH·S KanajiR R Montgomery
Jul 17, 2013·Journal of Thrombosis and Haemostasis : JTH·D Lillicrap
May 19, 2011·Annals of Medicine·Giuseppe LippiEmmanuel J Favaloro
Jul 19, 2016·Expert Review of Hematology·Massimo Franchini, Pier Mannuccio Mannucci
Jun 28, 2017·The Journal of Immunology : Official Journal of the American Association of Immunologists·Serena BettoniMarina Noris
May 18, 2018·Blood·Michael U CallaghanSteven W Pipe
Jul 26, 2019·Arteriosclerosis, Thrombosis, and Vascular Biology·Reheman Adili, Michael Holinstat
Jan 23, 2014·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Marcus StockschlaederUlrich Budde
Jul 27, 2018·Research and Practice in Thrombosis and Haemostasis·Veronica H FloodRobert R Montgomery
Sep 10, 2019·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Meaghan E CollingWalter H Dzik
Aug 31, 2019·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Chai W Phua, Erik Berntorp
Jun 18, 2021·Research and Practice in Thrombosis and Haemostasis·Daniel A KeeslerVeronica H Flood
Nov 3, 2020·Journal of Cardiothoracic and Vascular Anesthesia·Samhati MondalKenichi Tanaka

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.